Wells Fargo Initiates Coverage On Quest Diagnostics with Underweight Rating, Announces $100 Price Target

Wells Fargo analyst Dan Leonard initiates coverage on Quest Diagnostics (NYSE:DGX) with a Underweight rating and a $100 price target.

Benzinga · 01/08/2020 14:05

Wells Fargo analyst Dan Leonard initiates coverage on Quest Diagnostics (NYSE:DGX) with a Underweight rating and a $100 price target.